FILINGS
| ABIO 0000907654 | |||
|---|---|---|---|
| Filing Date | Form Type | Description | Document |
| 2024-08-20 | 4 | FORM 4 | View Document |
| 2024-08-16 | 425 | CURRENT REPORT | View Document |
| 2024-08-16 | 8-K | CURRENT REPORT | View Document |
| 2024-08-15 | 425 | CURRENT REPORT | View Document |
| 2024-08-15 | 8-K | CURRENT REPORT | View Document |
| 2024-08-09 | 425 | FORM 425 | View Document |
| 2024-08-01 | 425 | 425 | View Document |
| 2024-08-01 | 8-K | 8-K | View Document |
| 2024-08-01 | 424B3 | 424B3 | View Document |
| 2024-08-01 | 10-Q | 10-Q | View Document |
| 2024-07-26 | SEC STAFF LETTER | View Document | |
| 2024-07-26 | 4 | FORM 4 | View Document |
| 2024-07-24 | EFFECT | View Document | |
| 2024-07-24 | ARS | FORM ARS | View Document |
| 2024-07-23 | CORRESP | View Document | |
| 2024-07-22 | CORRESP | View Document | |
| 2024-07-22 | S-4/A | REGISTRATION STATEMENT | View Document |
| 2024-07-16 | UPLOAD | View Document | |
| 2024-07-12 | SEC STAFF LETTER | View Document | |
| 2024-07-12 | 4 | FORM 4 | View Document |
| 2024-07-12 | 3 | FORM 3 | View Document |
| 2024-07-09 | S-4/A | REGISTRATION STATEMENT | View Document |
| 2024-07-09 | CORRESP | View Document | |
| 2024-07-09 | 425 | CURRENT REPORT | View Document |
| 2024-07-09 | 8-K | CURRENT REPORT | View Document |
| 2024-07-05 | SC 13G/A | JHG PLC (JHBIF) OWNS 10% | View Document |
| 2024-07-03 | UPLOAD | View Document | |
| 2024-06-18 | CORRESP | View Document | |
| 2024-06-18 | S-4/A | REGISTRATION STATEMENT | View Document |
| 2024-06-11 | UPLOAD | View Document | |
| 2024-06-06 | 425 | FORM 425 | View Document |
| 2024-05-14 | S-4 | REGISTRATION STATEMENT | View Document |
| 2024-04-29 | SC 13G | SC 13G | View Document |
| 2024-04-25 | 425 | 425 | View Document |
| 2024-04-25 | 8-K | 8-K | View Document |
| 2024-04-25 | 10-Q | 10-Q | View Document |
| 2024-04-23 | 8-K | 8-K | View Document |
| 2024-04-15 | SC 13G | View Document | |
| 2024-04-11 | SC 13G | JANUS HENDERSON GROUP PLC OWNS 7.4% OF ARCA BIOPHARMA, INC | View Document |
| 2024-04-09 | SC 13G | View Document | |
| 2024-04-05 | SC 13G/A | SC 13G/A | View Document |
| 2024-04-05 | SC 13D | ARCA BIOPHARMA, INC. | View Document |
| 2024-04-04 | 8-K | 8-K | View Document |
| 2024-04-03 | 425 | 425 | View Document |
| 2024-04-03 | 8-K | 8-K | View Document |
| 2024-03-22 | 8-K | 8-K | View Document |
| 2024-02-07 | SC 13G/A | View Document | |
| 2024-02-06 | 8-K | 8-K | View Document |
| 2024-02-01 | 8-K | 8-K | View Document |
| 2024-02-01 | 10-K | 10-K | View Document |
| 2024-01-31 | 4 | PRIMARY DOCUMENT | View Document |
| 2024-01-31 | 4 | FORM 4 SUBMISSION | View Document |
| 2024-01-31 | 4 | FORM 4 SUBMISSION | View Document |
| 2024-01-31 | 4 | FORM 4 SUBMISSION | View Document |
| 2024-01-31 | 4 | FORM 4 SUBMISSION | View Document |
| 2024-01-31 | 4 | FORM 4 SUBMISSION | View Document |
| 2024-01-31 | 4 | FORM 4 SUBMISSION | View Document |
| 2024-01-31 | 8-K | 8-K | View Document |
| 2023-12-19 | ARS | ARS | View Document |
| 2023-12-19 | DEFA14A | DEFA14A | View Document |
| 2023-12-19 | DEF 14A | DEF 14A | View Document |
| 2023-12-05 | 8-K | 8-K | View Document |
| 2023-12-04 | 8-K | 8-K | View Document |
| 2023-10-18 | 8-K | 8-K | View Document |
| 2023-10-18 | 10-Q | 10-Q | View Document |
| 2023-09-11 | SC 13G | SC 13G | View Document |
| 2023-07-21 | 8-K | 8-K | View Document |
| 2023-07-21 | 10-Q | 10-Q | View Document |
| 2023-04-24 | 8-K | 8-K | View Document |
| 2023-04-24 | 10-Q | 10-Q | View Document |
| 2023-02-24 | 8-K | 8-K | View Document |
| 2023-02-24 | 10-K | 10-K | View Document |
| 2023-02-13 | 8-K | 8-K | View Document |
| 2023-02-08 | SC 13G/A | NONE | View Document |
| 2022-12-19 | 4 | OWNERSHIP DOCUMENT | View Document |
| 2022-12-19 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-12-19 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-12-19 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-12-19 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-12-19 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-12-19 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-12-19 | 3 | FORM 3 SUBMISSION | View Document |
| 2022-12-19 | 8-K | 8-K | View Document |
| 2022-12-09 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-12-09 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-12-09 | 8-K | 8-K | View Document |
| 2022-11-03 | DEFA14A | DEFA14A | View Document |
| 2022-11-03 | DEF 14A | DEF 14A | View Document |
| 2022-10-28 | 8-K | 8-K | View Document |
| 2022-10-28 | 10-Q | 10-Q | View Document |
| 2022-10-20 | 8-K | 8-K | View Document |
| 2022-08-02 | 8-K | 8-K | View Document |
| 2022-08-02 | 10-Q | 10-Q | View Document |
| 2022-07-08 | 4 | OWNERSHIP DOCUMENT | View Document |
| 2022-07-08 | 3 | OWNERSHIP DOCUMENT | View Document |
| 2022-07-08 | SC 13D/A | AMENDMENT NO. 6 TO THE SCHEDULE 13D | View Document |
| 2022-06-21 | 4 | OWNERSHIP DOCUMENT | View Document |
| 2022-06-21 | 3 | OWNERSHIP DOCUMENT | View Document |
| 2022-06-21 | SC 13D/A | AMENDMENT NO. 5 TO THE SCHEDULE 13D | View Document |
| 2022-06-21 | 8-K | 8-K | View Document |
Search company filings and access detailed reports including 10-K, 10-Q, 8-K, and other critical filings. Stay informed on corporate disclosures, regulatory filings, and updates with our easy-to-use EDGAR API filings search tool.
